Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Follow-Up Questions
What is Smith & Nephew PLC (SNN)'s P/E Ratio?
The P/E ratio of Smith & Nephew PLC is N/A
Who is the CEO of Smith & Nephew PLC?
Mr. Deepak Nath is the Chief Executive Officer of Smith & Nephew PLC, joining the firm since 2022.
What is the price performance of SNN stock?
The current price of SNN is 37.04, it has increased 0.02% in the last trading day.
What are the primary business themes or industries for Smith & Nephew PLC?
Smith & Nephew PLC belongs to Health Care industry and the sector is Health Care
What is Smith & Nephew PLC market cap?
Smith & Nephew PLC's current market cap is $16
Is Smith & Nephew PLC a buy, sell, or hold?
According to wall street analysts, 18 analysts have made analyst ratings for Smith & Nephew PLC, including 6 strong buy, 8 buy, 9 hold, 0 sell, and 6 strong sell
